CyteQuest publishes new article in Scientific Reports
CyteQuest presents at the Cornell NanoScale Facility’s 2022 Annual Meeting
October 2022: CyteQuest engages with the local nanoscale community at Cornell University and presents its proprietary flow electroporation chip design at the CNF 2022 Annual Meeting.
CyteQuest presents at BPI's Biotech Week Boston 2022
September 2022: CyteQuest showcases data from transfection of primary T cells in a poster presentation at Biotech Week Boston in the Cell & Gene Therapy Manufacturing section. Download our poster below.
CyteQuest receives $0.2 million grant from NIH
July 2022: CyteQuest is awarded $0.2 million SBIR Phase I grant from National Institute of General Medical Sciences, a division of the National Institutes of Health to develop an adaptable and scalable platform for cellular therapy. Read more
CyteQuest raises $1.1 million in new equity investment
November 2020: In pursuit of transforming non-viral cell engineering, CyteQuest secures $1.1 million in new equity investment to enable development of its proprietary flow electroporation technology. Read more
L2022 CyteQuest Boston Biotech Week Poster (pdf)